Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Lutz

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesicsM W Lutz, P H Morgan, M K James, et al.
The Pharmacogenomics Journal|December 24, 2009
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseA D Roses, M W Lutz, H Amrine-Madsen, et al.
Clinical Pharmacology and Therapeutics|December 20, 2012
Using genetics to enable studies on the prevention of Alzheimer's diseaseD G Crenshaw, W K Gottschalk, M W Lutz, et al.
Translational Psychiatry|September 24, 2014
Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?D M Lyall, S E Harris, M E Bastin, et al.
Molecular Psychiatry|December 5, 2012
A genome-wide association study implicates the APOE locus in nonpathological cognitive ageingG Davies, S E Harris, C A Reynolds, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesicsM W Lutz, P H Morgan, M K James, et al.
The Pharmacogenomics Journal|December 24, 2009
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseA D Roses, M W Lutz, H Amrine-Madsen, et al.
Clinical Pharmacology and Therapeutics|December 20, 2012
Using genetics to enable studies on the prevention of Alzheimer's diseaseD G Crenshaw, W K Gottschalk, M W Lutz, et al.
Translational Psychiatry|September 24, 2014
Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?D M Lyall, S E Harris, M E Bastin, et al.
Molecular Psychiatry|December 5, 2012
A genome-wide association study implicates the APOE locus in nonpathological cognitive ageingG Davies, S E Harris, C A Reynolds, et al.
Pageof 2